Last reviewed · How we verify

NCT03688087: BOUGE GROSSESS

Study of Programm Interest 'Bouge' to Improve the Daily Physical Activity at the Pregnant Women.

Status unknown NA Last updated 28 September 2018
What this trial tests

NA trial testing Smartphone application "placebo" in Physical Activity in 250 participants. Status unknown.

Timeline
22 August 2017
Primary endpoint
22 October 2018
22 October 2018

Quick facts

Lead sponsorUniversity Hospital, Brest
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment250
Start date22 August 2017
Primary completion22 October 2018
Estimated completion22 October 2018
Sites4 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, female only, with Physical Activity or Pregnant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of pregnant patients beguining at 15 SA

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A smartphone coaching program ("Bouge Grossesse") improves daily physical activity in pregnant women.
    Muller M, James P, Merviel P, Saraux A, et al · · 2026 · PMID 39277170 · DOI 10.1016/j.jogoh.2024.102847

Verify or expand the search:

Other trials of Smartphone equipped with application "bouge" = Coach group

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03688087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing